March 14, 2022
AYOXXA Receives Fresh Capital for Commercial Growth in Europe, US and Asia Led by Prosnav Capital
AYOXXA Biosystems GmbH has announced the successful closing of a financing round which will provide runway for the coming 3 – 5 years. The round was led by Hong Kong-based strategic investor, Prosnav Capital, who will provide AYOXXA access to the Asian market with a broad regional network. Besides Prosnav, a group of existing shareholders participated in the financing.